AhmedOKasebMD

PubMed

• Phase I Trial of SPECT-Guided Liver-Directed Radiotherapy for Patients with Low Functional Liver Volume.
  Enoch Chang, Franklin C L Wong, Beth A Chasen, William D Erwin, Prajnan Das, Emma B Holliday, Albert C Koong, Ethan B Ludmir, Bruce D Minsky, Sonal S Noticewala, Grace...> ;JNCI Cancer Spectrum. 2024 May 10
• 1 citations
  Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
  John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, Eliza Beal, Richard S Finn, Terence P Gade, Laura Goff, Shilpi Gupta, Jennifer Guy, Hang T Hoang, Renuka Iyer, Ishm...> ;Journal of Clinical Oncology. 2024 Mar 19
• Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer.
  Prashant Dogra, Vrushaly Shinglot, Javier Ruiz-Ramírez, Joseph Cave, Joseph D Butner, Carmine Schiavone, Dan G Duda, Vittorio Cristini, Bulent Ozpolat, George A Calin,...> ;Medrxiv. 2024 Mar 15
• Genome-wide association study identifies high-impact susceptibility loci for HCC in North America.
  Manal M Hassan, Donghui Li, Younghun Han, Jinyoung Byun, Rikita I Hatia, Erping Long, Jiyeon Choi, Robin Kate Kelley, Sean P Cleary, Anna S Lok, Paige Bracci, Jennifer...> ;Hepatology. 2024 Feb 20
• 2 citations
  Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
  Yau, T., Kaseb, A., Cheng, A., Qin, S., Zhu, A., Chan, S., Melkadze, T., Sukeepaisarnjaroen, W., Breder, V., Verset, G., Gane, E., Borbath, I., Rangel, J., Ryoo, B., M...> ;The Lancet. Gastroenterology & Hepatology. 2024 Apr 1
• 1 citations
  A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma.
  Lorenz Balcar, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Katharina Pomej, Marta Bofill Roig, Elias Laurin Meyer, Jaekyung Che, Naoshi Nishid...> ;JHEP Reports. 2024 Feb 1
• Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
  Oluwadunni E Emiloju, Jun Yin, Emily Koubek, Joel M Reid, Mitesh J Borad, Yanyan Lou, Mahesh Seetharam, Martin J Edelman, Edward A Sausville, Yixing Jiang, Ahmed O Kas...> ;Investigational New Drugs. 2024 Feb 1
• Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma.
  Shadi Chamseddine, Michael LaPelusa, Lianchun Xiao, Yehia I Mohamed, Sunyoung S Lee, Zishuo Ian Hu, Rikita I Hatia, Manal Hassan, James C Yao, Dan G Duda, Saumil Datar...> ;Journal of Hepatocellular Carcinoma. 2024 Jan 1
• Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection.
  Maen, A., Mohamed, Y., Esmail, A., Lu, J., Azmi, A., Kaseb, M., Kasseb, O., Li, D., Gocio, M., Kocak, M., Selim, A., Ma, Q., Gok Yavuz, B., Mohamed, A., Kaseb, A.> ;Frontiers in Pharmacology. 2024 Jan 1
• Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features.
  Tran Cao, H., Witt, R., Elsayes, K., Baiomy, A., Xiao, L., Palmquist, S., Lee, S., Mohamed, Y., Mahvash, A., Tzeng, C., Chun, Y., Koay, E., Rashid, A., Hassan, M., Yao...> ;The Oncologist. 2023 Dec 30
• Author Correction: Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers.
  David Hsiehchen, Leslie Bucheit, Dong Yang, Muhammad Shaalan Beg, Mir Lim, Sunyoung S Lee, Pashtoon Murtaza Kasi, Ahmed O Kaseb, Hao Zhu> ;Nature Communications. 2023 Nov 22
• 2 citations
  Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.
  Dharmapuri, S., Özbek, U., Jethra, H., Jun, T., Marron, T., Saeed, A., Huang, Y., Muzaffar, M., Pinter, M., Balcar, L., Fulgenzi, C., Amara, S., Weinmann, A., Personen...> ;World Journal of Gastrointestinal Oncology. 2023 Nov 15
• Transplant Oncology: An Emerging Discipline of Cancer Treatment.
  Maen Abdelrahim, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, David Victor, Sudha Kodali, Yee Lee Cheah, Caroline J Simon, Mazen Noureddin, Ashton Connor, Ashish Sa...> ;Cancers. 2023 Nov 9
• 1 citations
  Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.
  Vincent Joerg, Bernhard Scheiner, Antonio D Alessio, Claudia A M Fulgenzi, Martin Schönlein, Lorenz Kocheise, Ansgar W Lohse, Samuel Huber, Henning Wege, Ahmed Kaseb, ...> ;Hepatology Communications. 2023 Nov 1
• 23 citations
  Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label...
  Shukui Qin, Minshan Chen, Ann-Lii Cheng, Ahmed O Kaseb, Masatoshi Kudo, Han Chu Lee, Adam C Yopp, Jian Zhou, Lu Wang, Xiaoyu Wen, Jeong Heo, Won Young Tak, Shinichiro ...> ;Lancet. 2023 Nov 18
• The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.
  Betul Gok Yavuz, Saumil Datar, Shadi Chamseddine, Yehia I Mohamed, Michael LaPelusa, Sunyoung S Lee, Zishuo Ian Hu, Eugene J Koay, Hop S Tran Cao, Prasun Kumar Jalal, ...> ;Cancers. 2023 Oct 7
• ASO Visual Abstract: Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma.
  Douglas S Swords, Timothy E Newhook, Ching-Wei D Tzeng, Nader N Massarweh, Yun Shin Chun, Sunyoung Lee, Ahmed O Kaseb, Mark Ghobrial, Jean-Nicolas Vauthey, Hop S Tran Cao> ;Annals of Surgical Oncology. 2023 Dec 1
• Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma.
  Douglas S Swords, Timothy E Newhook, Ching-Wei D Tzeng, Nader N Massarweh, Yun Shin Chun, Sunyoung Lee, Ahmed O Kaseb, Mark Ghobrial, Jean-Nicolas Vauthey, Hop S Tran Cao> ;Annals of Surgical Oncology. 2023 Nov 1
• 1 citations
  Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors.
  Yibirin, M., Mustafayev, K., Hosry, J., Pundhir, P., Klingen, J., Yepez Guevara, E., Granwehr, B., Kaseb, A., Naing, A., Patel, S., Shah, A., Skoulidis, F., Tawbi, H.,...> ;The American Journal of Gastroenterology. 2023 Sep 1
• 57 citations
  Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international pha...
  Shukui Qin, Stephen L Chan, Shanzhi Gu, Yuxian Bai, Zhenggang Ren, Xiaoyan Lin, Zhendong Chen, Weidong Jia, Yongdong Jin, Yabing Guo, Xiaohua Hu, Zhiqiang Meng, Jun Li...> ;Lancet. 2023 Sep 30
• 4 citations
  Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma-A Narrative Review.
  Shadi Chamseddine, Michael LaPelusa, Ahmed Omar Kaseb> ;Cancers. 2023 Jul 5
• Correction: Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALKT-cell lymphoma.
  Bhawana George, Suraj Konnath George, Wenyu Shi, Abedul Haque, Ping Shi, Ghazaleh Eskandari, Magnus Axelson, Olle Larsson, Ahmed O Kaseb, Hesham M Amin> ;Journal of Hematology & Oncology. 2023 Jun 13
• Salvage Locoregional Therapy Following Progression After Radiotherapy for Hepatocellular Carcinoma Is Associated with Improved Outcomes.
  Yuan-Mao Lin, Bryan M Fellman, Ryosuke Taiji, Iwan Paolucci, Jessica Albuquerque Marques Silva, Eugene J Koay, Rony Avritscher, Armeen Mahvash, Emma B Holliday, Sunyou...> ;Journal of Gastrointestinal Surgery. 2023 Sep 1
• 6 citations
  Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.
  Li Gu, Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T Ryujin, Jian Yu Huang, Shusil K Pandit, Shadi Chamseddine, Lianchun Xiao, Yehia I Mohamed, Ahmed O Kaseb, Michael...> ;Proceedings of the National Academy of Sciences of the United States of America. 2023 May 9
• 2 citations
  The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal Cancers.
  Michael S Lee, Ahmed O Kaseb, Shubham Pant> ;Clinical Cancer Research. 2023 Sep 1
• Join now to see all

Journal Articles

• Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study  
  Felipe Samaniego, Boris Blechacz, Ahmed Kaseb, Bruno P Granwehr, Aung Naing, Issam I Raad, Ethan Miller, Harrys A Torres, Nature

Lectures

• Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC. 
  ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
• Randomized, open-label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC. 
  2019 ASCO Annual Meeting - 6/1/2019